GAITHERSBURG, Md., May 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the Company), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today reported financial results for the three months ended March 31, 2011.
